2023-05-04 09:39:12 ET
- Surface Oncology press release ( NASDAQ: SURF ): Q1 GAAP EPS of -$0.33 beats by $0.04 .
-
As of March 31, 2023, cash, cash equivalents and marketable securities were $102.1 million, compared to $124.8 million on December 31, 2022.
- General and administrative (G&A) expenses were $5.9 million for the first quarter ended March 31, 2023, compared to $6.5 million for the same period in 2022.
- Research and development (R&D) expenses were $13.8 million for the first quarter ended March 31, 2023, compared to $16.6 million for the same period in 2022.
For further details see:
Surface Oncology GAAP EPS of -$0.33 beats by $0.04